A detailed history of Richard P Slaughter Associates Inc transactions in Novartis Ag stock. As of the latest transaction made, Richard P Slaughter Associates Inc holds 15,472 shares of NVS stock, worth $1.61 Million. This represents 0.52% of its overall portfolio holdings.

Number of Shares
15,472
Previous 16,033 3.5%
Holding current value
$1.61 Million
Previous $1.71 Million 4.28%
% of portfolio
0.52%
Previous 0.45%

Shares

20 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2024

Oct 07, 2024

SELL
$106.13 - $120.89 $59,538 - $67,819
-561 Reduced 3.5%
15,472 $1.78 Million
Q2 2024

Jul 10, 2024

BUY
$92.57 - $107.37 $96,735 - $112,201
1,045 Added 6.97%
16,033 $1.71 Million
Q1 2024

Apr 09, 2024

SELL
$95.27 - $108.47 $42,204 - $48,052
-443 Reduced 2.87%
14,988 $1.45 Million
Q4 2023

Jan 08, 2024

SELL
$92.27 - $101.54 $46,780 - $51,480
-507 Reduced 3.18%
15,431 $1.56 Million
Q3 2023

Oct 10, 2023

BUY
$94.73 - $105.13 $10,609 - $11,774
112 Added 0.71%
15,938 $1.62 Million
Q2 2023

Jul 06, 2023

SELL
$92.52 - $104.91 $49,868 - $56,546
-539 Reduced 3.29%
15,826 $1.6 Million
Q1 2023

Apr 18, 2023

SELL
$80.03 - $92.81 $1,680 - $1,949
-21 Reduced 0.13%
16,365 $1.51 Million
Q4 2022

Jan 09, 2023

BUY
$75.55 - $92.52 $31,655 - $38,765
419 Added 2.62%
16,386 $0
Q3 2022

Oct 11, 2022

BUY
$74.61 - $87.26 $60,657 - $70,942
813 Added 5.36%
15,967 $1.21 Million
Q2 2022

Jul 08, 2022

BUY
$80.52 - $93.75 $82,130 - $95,625
1,020 Added 7.22%
15,154 $1.28 Million
Q1 2022

Apr 11, 2022

BUY
$80.11 - $90.62 $123,048 - $139,192
1,536 Added 12.19%
14,134 $1.24 Million
Q4 2021

Jan 13, 2022

SELL
$79.7 - $88.13 $23,670 - $26,174
-297 Reduced 2.3%
12,598 $1.1 Million
Q3 2021

Oct 06, 2021

BUY
$81.78 - $95.14 $102,388 - $119,115
1,252 Added 10.75%
12,895 $1.05 Million
Q2 2021

Jul 12, 2021

SELL
$85.24 - $94.15 $85 - $94
-1 Reduced 0.01%
11,643 $1.06 Million
Q1 2021

Apr 14, 2021

SELL
$83.5 - $98.47 $33,316 - $39,289
-399 Reduced 3.31%
11,644 $995,000
Q4 2020

Jan 20, 2021

BUY
$78.07 - $94.43 $29,354 - $35,505
376 Added 3.22%
12,043 $1.14 Million
Q3 2020

Oct 13, 2020

SELL
$82.14 - $91.0 $105,057 - $116,389
-1,279 Reduced 9.88%
11,667 $1.01 Million
Q2 2020

Jul 09, 2020

BUY
$80.93 - $91.1 $3,884 - $4,372
48 Added 0.37%
12,946 $1.13 Million
Q1 2020

May 28, 2020

BUY
$70.67 - $99.01 $39,363 - $55,148
557 Added 4.51%
12,898 $1.06 Million
Q4 2019

May 27, 2020

BUY
$84.35 - $95.37 $1.04 Million - $1.18 Million
12,341 New
12,341 $1.17 Million

Others Institutions Holding NVS

About NOVARTIS AG


  • Ticker NVS
  • Exchange OTC
  • Sector Healthcare
  • Industry Drug Manufacturers—General
  • Shares Outstandng 2,151,000,064
  • Market Cap $224B
  • Description
  • Novartis AG researches, develops, manufactures, and markets healthcare products worldwide. The company operates through two segments, Innovative Medicines and Sandoz. The Innovative Medicines segment offers prescription medicines for patients and healthcare providers. It also provides ophthalmology, neuroscience, immunology, hepatology, dermatol...
More about NVS
Track This Portfolio

Track Richard P Slaughter Associates Inc Portfolio

Follow Richard P Slaughter Associates Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Richard P Slaughter Associates Inc, based on Form 13F filings with the SEC.

News

Stay updated on Richard P Slaughter Associates Inc with notifications on news.